Nuplazid Adverse Event Report 2018

$19.99

This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions

Description

Nuplazid (pimavanserin) is an antipsychotic medicine that works by changing the actions of chemicals in the brain. Nuplazid is used to treat hallucinations and delusions caused by psychosis that is related to Parkinson’s disease.https://www.drugs.com/nuplazid.html